Response to the Article on Antibiotics and Immune Checkpoint Inhibitors by Lin et al.


First-Page Preview
Abstract of Reply References Lin KY, Tang SC, Zhang CW, Zeng YY, Yang T. Impact of antibiotics use on cancer-related and all-cause mortality among patients receiving immunotherapy for advanced hepatocellular carcinoma. Liver Cancer. 2022; doi: 10.1159/000525028. Cheung KS, Lam LK, Seto WK, Leung WK. Use of antibiotics during immune checkpoint inhibitor treatment is associated with lower survival in hepatocellular carcinoma. Liver Cancer. 2021;10(6):606–14. Erratum. Liver Cancer. 2022; doi: ■■■. Article / Publication Details

Received: June 08, 2022
Accepted: July 02, 2022
Published online: July 13, 2022

Number of Print Pages: 3
Number of Figures: 2
Number of Tables: 0

ISSN: 2235-1795 (Print)
eISSN: 1664-5553 (Online)

For additional information: https://www.karger.com/LIC

Figures Thumbnail Thumbnail Open Access License / Drug Dosage / Disclaimer This article is licensed under the Creative Commons Attribution-NonCommercial 4.0 International License (CC BY-NC). Usage and distribution for commercial purposes requires written permission. Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug. Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.

留言 (0)

沒有登入
gif